Supplement to License and Supply Agreement Sample Contracts

A Supplement (hereinafter referred to as “Supplement”) to OXFORD-SSI Amended and Restated License and Supply Agreement (hereinafter re-ferred to as the “Agreement”). Background:

Supplement to License and Supply Agreement • October 25th, 2013 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances

• Contract Type
  Supplement to License and Supply Agreement
• Filed
  October 25th, 2013
• Company
  Oxford Immunotec Global PLC
• Industry
  In vitro & in vivo diagnostic substances

Whereas, SSI advised OXFORD that the opportunity to file a patent application directed towards the M.tuberculosis antigen TB12.3 would expire on October 1, 2010 and that SSI did not believe this antigen to be of importance within TB vac-cine production and/or TB diagnostic; and